Trial · NCT01210352
Participant flow27
How many started, completed or left each group, period by period.
1 to 20 of 27
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Single Dose Phase 6 to ≤12 Years Age Group: 0.05 mg/kg | 6 | |
| Overall Study | STARTED | Single-Dose Phase 6 to ≤12 Years Age Group: 0.10 mg/kg | 6 | |
| Overall Study | STARTED | Single Dose Phase 6 to ≤12 Years Age Group: 0.20 mg/kg | 7 | |
| Overall Study | STARTED | Single Dose Phase 2 to <6 Years Age Group: 0.05 mg/kg | 7 | |
| Overall Study | STARTED | Single Dose Phase 2 to <6 Years Age Group: 0.10 mg/kg | 6 | |
| Overall Study | STARTED | Single Dose Phase 2 to <6 Years Age Group: 0.20 mg/kg | 6 | |
| Overall Study | STARTED | Single Dose Phase 0 to < 2 Years Age Group: 0.05 mg/kg | 7 | |
| Overall Study | STARTED | Multiple Dose Phase 6 to ≤12 Years Age Group: 0.20 mg/kg | 10 | |
| Overall Study | STARTED | Multiple Dose Phase 2 to <6 Years Age Group: 0.20 mg/kg | 6 | |
| Overall Study | COMPLETED | Single Dose Phase 6 to ≤12 Years Age Group: 0.05 mg/kg | 6 | |
| Overall Study | COMPLETED | Single-Dose Phase 6 to ≤12 Years Age Group: 0.10 mg/kg | 6 | |
| Overall Study | COMPLETED | Single Dose Phase 6 to ≤12 Years Age Group: 0.20 mg/kg | 5 | |
| Overall Study | COMPLETED | Single Dose Phase 2 to <6 Years Age Group: 0.05 mg/kg | 7 | |
| Overall Study | COMPLETED | Single Dose Phase 2 to <6 Years Age Group: 0.10 mg/kg | 6 | |
| Overall Study | COMPLETED | Single Dose Phase 2 to <6 Years Age Group: 0.20 mg/kg | 6 | |
| Overall Study | COMPLETED | Single Dose Phase 0 to < 2 Years Age Group: 0.05 mg/kg | 5 | |
| Overall Study | COMPLETED | Multiple Dose Phase 6 to ≤12 Years Age Group: 0.20 mg/kg | 7 | |
| Overall Study | COMPLETED | Multiple Dose Phase 2 to <6 Years Age Group: 0.20 mg/kg | 2 | |
| Overall Study | NOT COMPLETED | Single Dose Phase 6 to ≤12 Years Age Group: 0.05 mg/kg | 0 | |
| Overall Study | NOT COMPLETED | Single-Dose Phase 6 to ≤12 Years Age Group: 0.10 mg/kg | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01210352/flow